
BPC-157
CLEARED PEPTIDES · Lot US26BPC502
- Labeled amount
- 5.0 mg
- Measured amount
- 5.8 mg
- Identity · LC-MS
- Confirmed
- Analysis completed

Findings relate to the tested sample and recorded method. See the full report.
$34.99 – $100.00Price range: $34.99 through $100.00
BPC-157 is a research material associated with peptide signaling research. Intended for laboratory research and analytical use only; not for human or veterinary use.
Discount per quantity
| Quantity | 2 | 3 | 4 | 5 | 10 - 15 |
|---|---|---|---|---|---|
| Price | $31.49 – $90.00Price range: $31.49 through $90.00 | $29.74 – $85.00Price range: $29.74 through $85.00 | $27.99 – $80.00Price range: $27.99 through $80.00 | $26.24 – $75.00Price range: $26.24 through $75.00 | $24.49 – $70.00Price range: $24.49 through $70.00 |
Molecular Structure Explorer
Structure of the compound on this page.

BPC-157 from Cleared Peptides is a research-grade compound supplied for laboratory and analytical investigation. Every lot is third-party tested, and the batch Certificate of Analysis is published before sale. Specifications, CAS number and molecular formula are listed below.
| Compound | BPC-157 |
|---|---|
| Synonyms | Body Protection Compound 157; PL 14736 |
| CAS Number | 137525-51-0 |
| PubChem CID | 9941957 |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.5 g/mol |
| Sequence / Structure | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Form | Lyophilized (freeze-dried) powder |
| Purity | ≥99% by HPLC (verified per batch – see COA) |
| Storage | Store at −20 °C, sealed, dry and protected from light. Allow vial to reach room temperature before opening. |
BPC-157 (Body Protection Compound 157, also coded PL 14736) is a 15-residue synthetic peptide whose sequence corresponds to a fragment of a protein first isolated from gastric juice. Because it is stable in aqueous solution and short enough to synthesize at high purity, it is widely used as a reference peptide in cell-culture studies.
Published in-vitro work has examined BPC-157 in endothelial-cell and fibroblast models, including cell-migration assays, nitric-oxide signaling and growth-factor receptor (VEGFR2, FAK–paxillin) pathway studies. It is frequently studied alongside TB-500 (Thymosin Beta-4), which is why we also offer a pre-combined BPC-157 + TB-500 blend.
This summary describes published laboratory research only and makes no claim about effects in humans or animals.
Each lot of BPC-157 is analyzed by an independent laboratory, with identity and purity (or composition, for multi-component preparations) reported on a lot-specific Certificate of Analysis. View current results on our COA page.
Store at −20 °C, sealed, dry and protected from light. Allow vial to reach room temperature before opening. Minimize freeze–thaw cycles and handle according to your institution’s chemical-hygiene procedures.
BPC-157 is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (C62H98N16O22, MW 1419.5 g/mol, CAS 137525-51-0).
Yes. Every lot of BPC-157 is tested by an independent laboratory for identity and purity, and the batch Certificate of Analysis is published on our COA page.
Yes. Lot-specific COAs are posted on our COA page so you can review analytical data before purchase.
RUO products are supplied solely for laboratory and analytical research. They are not medicines, are not for human or veterinary use, and no dosing or administration information is provided.
Store at −20 °C, sealed, dry and protected from light. Allow vial to reach room temperature before opening.
Learn more: BPC-157 research guide · BPC-157 vs TB-500 comparison
Research use only. BPC-157 is supplied for laboratory research. It is not a drug, food, cosmetic, or dietary supplement. It is not FDA-approved. It is not for human or veterinary administration. This page does not give a dose or a method of administration. A study cited on this page describes that study’s own test article. It does not make this lot an approved medicine. To check a fact, open the PubMed or DOI link, confirm the authors and year, and match the paper’s compound name, CAS number, or sequence to the specification table. The full method is on the research desk page. Identity and purity for a lot are only what that lot’s certificate of analysis reports. An HPLC percentage is not a sterility result and not an endotoxin result unless the certificate prints those tests.
Written by the Cleared Peptides Research Desk, the editorial desk of Cleared Wellness Group LLC. This is not a personal profile of a physician or a scientist, and it is not a fictional author. The checking method is public on the research desk page. Last reviewed October 2026.
Research use only. This BPC-157 material is for laboratory research, CAS 137525-51-0. It is not a drug. The experimental literature summarized below is not a dosing guide, and this page does not provide one.
The specification is the pentadecapeptide Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, formula C62H98N16O22, mass about 1419.5 g/mol. The sequence is short and proline-rich. It retains poorly on a plain C18 column unless the mobile phase uses an ion-pairing acid, and it has little absorbance at 280 nm, so 214 nm is the usual detection wavelength. Mass spectrometry is what distinguishes this sequence from another short peptide with a similar retention time. A “BPC” label without this mass is not this specification. The acetate or other counterion is invisible to an area-percent HPLC purity number.
Most experimental reports on this sequence come from one research community, centered on Predrag Sikiric and Sven Seiwerth and their coworkers. Two reviews from that community are the secondary sources used here, because they state the scope of the claim in the authors’ own words.
Seiwerth, Rucman, Turkovic, and colleagues (Current Pharmaceutical Design, 2018) review BPC-157 against epidermal growth factor, fibroblast growth factor, and vascular endothelial growth factor, and they extend the discussion from gastrointestinal lesions to tendon, ligament, muscle, and bone models. The paper is a review of that group’s pharmacology, not an independent multi-center replication. PubMed 29998800, DOI 10.2174/1381612824666180712110447.
Seiwerth, Milavic, Vukojevic, and colleagues (Frontiers in Pharmacology, 2021) review the same peptide’s wound-healing literature, again from within that program. PubMed 34267654, DOI 10.3389/fphar.2021.627533.
A long reference list is not the same thing as many independent groups. When the same laboratories generate the lesion models, the peptide batches, and the reviews, a reader should weight the chemistry (sequence, mass, purity) more heavily than the volume of citations. This desk is not claiming the papers are false. It is claiming they should be read as a concentrated preclinical literature. Where a paper says “healing,” the subject is the animal or tissue model in that paper. It is not this vial, and it is not a human-use instruction. This note does not cite an outside replication, because the sources checked for this page did not add one that met the same standard. If you have a DOI from a separate group, the desk can add it after the same author-and-sequence check.
BPC-157 and the 43-residue thymosin β4 protein sold as TB-500 are unrelated sequences. A blend does not inherit either review. See the comparison and the blend product, which has to show both masses.
Peer-reviewed literature on BPC-157, listed as scientific background for laboratory researchers. Citation does not imply endorsement by the authors or any use other than in-vitro research.
For laboratory research use only. This product is not a drug, food, cosmetic or dietary supplement, is not FDA-approved, and is not intended for human or veterinary use or for the diagnosis, treatment, cure, mitigation or prevention of any disease. No dosing, administration or therapeutic information is provided. Sold only to qualified researchers; the purchaser is responsible for safe handling and compliance with all applicable laws and institutional requirements.
Choose a report to see its lab results, purity and measured amount. Match the MG amount and lot number to your product.
BPC-157
Tap this certificate to view the full certificate.
Certificate of Analysis issued by Reinstoff Labs. Batch ID: US26BPC502 · HPLC purity: — · Report code: RL-2026-000822

CLEARED PEPTIDES · Lot US26BPC502

Findings relate to the tested sample and recorded method. See the full report.
Issued by Reinstoff Labs. For research use only.
Tap this certificate to view the full certificate.
Certificate of Analysis issued by Reinstoff Labs. Batch ID: US26BPC501 · HPLC purity: 99.3% · Report code: RL-2026-000821

CLEARED PEPTIDES · Lot US26BPC501

Findings relate to the tested sample and recorded method. See the full report.
Issued by Reinstoff Labs. For research use only.
BPC-157 · IN2026100025
BPC-157
View the certificate for the reported test results.
This website contains information about research compounds intended strictly for laboratory, analytical, and research purposes. These products are not intended for human or animal consumption, diagnostic use, or therapeutic use of any kind. By entering this site you confirm the statements below.
Sign in or create your account in seconds.
We sent a 6-digit code by text to .
It isn't on an account yet. Add your name and email to create one. Already registered? Use your email and password once, and this phone will sign you in next time.
This number is saved on more than one account. Enter that account's email. The text code already verified the number, so no password is needed.
Next time, skip the password – we'll just text you a code.
Taking you to the lab…
Disclaimer. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. All peptide research products on this site are for research and development use only. Cleared Peptides is not a compounding pharmacy or outsourcing facility. Research Use Only products sold here are intended solely for basic research, pharmaceutical research, or the development of new tests. These products are not intended for human dosing, injection, or ingestion.
© 2026 Cleared Peptides. All rights reserved.